Repository

Publications

Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in Cholangiocarcinoma

Tesini G, Braconi C, Rimassa L, Macias RIR
Cancers (Basel) . 2025 Jan 6;17(1):156. doi: 10.3390/cancers17010156
2025 

Ganglioside GD2 Contributes to a Stem-Like Phenotype in Intrahepatic Cholangiocarcinoma

Mannini A, Pastore M, Giachi A, Correnti M, Spínola Lasso E, Lottini T, Piombanti B, Tusa I, Rovida E, Coulouarn C, Andersen JB, Lewinska M, Campani C, Battula VL, Yuan B, Aureli M, Carsana EV, Peraldo Neia C, Ostano P, Tani A, Nosi D, Vanni A, Maggi L, Di Tommaso L, Comito G, Madiai S, Arcangeli A, Marra F, Raggi C.
Liver Int. 2025 Jan;45(1):e16208. doi: 10.1111/liv.16208.
2025 

Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma

Zhuravleva E, Lewinska M, O'Rourke CJ, Pea A, Rashid A, Hsing AW, Taranta A, Chang D, Gao YT, Koshiol J, Oliveira RC, Andersen JB
Gut. 2024 Dec 26:gutjnl-2024-333368. doi: 10.1136/gutjnl-2024-333368
2024 

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

Lo Prinzi F, Salani F, Rimini M, Rizzato MD, Antonuzzo L, Camera S, Satake T, Vandeputte H, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Melo Alvim C, Roque R, Fornaro L, De Rosa A, Lavacchi D, Rossari F, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Viola MG, Silvestro L, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, Ahcene Djaballah S, Zanuso V, Masi G, Lonardi S, Rimassa L, Casadei-Gardini A.
Oncologist. 2024 Oct 19:oyae256. doi: 10.1093/oncolo/oyae256
2024 
Funded by

Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3.

Asensio M, Briz O, Herraez E, Perez-Silva L, Espinosa-Escudero R, Bueno-Sacristan D, Peleteiro-Vigil A, Hammer H, Pötz O, Kadioglu O, Banales JM, Martinez-Chantar ML, Avila MA, Macias RIR, Efferth T, Marin JJG, Lozano E.
Biomed Pharmacother. 2024 Oct 13;180:117533. doi: 10.1016/j.biopha.2024.117533
2024 
Join the Action
JOIN